U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07069868) titled 'Telehealth in an Ambulatory Oncology Phase I Clinical Trial Unit' on Jan. 24.
Brief Summary: The study aimed to evaluate the feasibility, acceptability, satisfaction and effectiveness of telehealth on early identification and mitigation of adverse events during cycle one of a Phase 1 oncology clinical trial.
Study Start Date: Aug. 12, 2021
Study Type: INTERVENTIONAL
Condition:
Malignant Neoplasm
Intervention:
OTHER: Telehealth
During cycle one, participants will be asked about fevers, mucositis, nausea, vomiting, constipation, diarrhea, dyspnea, cough, rash, pain and fever. Symptoms will be graded according to Common Terminol...